Skip to Content

Dorzolamide 2% and Timolol 0.5% Ophthalmic Solution

Last Updated: January 29, 2018
Status: Current

Dorzolamide 2% and Timolol 0.5% Ophthalmic Solution

Products Affected - Description
  • Cosopt ophthalmic solution, Akorn
    22.3 mg-6.8 mg/mL, 10 mL Ocumeter Plus bottle, 1 count (NDC 17478-0605-10)

 
Dorzolamide and Timolol ophthalmic solution, Akorn
22.3 mg-6.8 mg/mL, 10 mL bottle, 1 count (NDC 50383-0233-10)
 
Dorzolamide and Timolol ophthalmic solution, Sandoz
22.3 mg-6.8 mg/mL, 10 mL bottle, 1 count (NDC 61314-0030-02)
 
Dorzolamide and Timolol ophthalmic solution, Teva
22.3 mg-6.8 mg/mL, 10 mL bottle, 1 count (NDC 00591-2482-79)

Dorzolamide and Timolol ophthalmic solution, Valeant
22.3 mg-6.8 mg/mL, 10 mL bottle, 1 count (NDC 24208-0486-10)
Reason for the Shortage
    • Akorn has dorzolamide and timolol ophthalmic solution on shortage due to manufacturing delays.
    • Sandoz did not provide a reason for the shortage.
    • Teva did not provide a reason for the shortage.
    • Valeant did not provide a reason for the shortage.
Available Products
  • Cosopt PF ophthalmic solution, Akorn
    22.3 mg-6.8 mg/mL, 0.2 mL single-use preservative-free vial, 60 count, (NDC 17478-0604-30)

Estimated Resupply Dates

    • Akorn has dorzolamide 2% and timolol 0.5% ophthalmic solution on allocation. The company has Cosopt 2%/0.5% ophthalmic solution available but with an expiration date of August 2018.
    • Sandoz has dorzolamide 2% and timolol 0.5% ophthalmic solution on back order and the company estimates a release date of mid- to late-February 2018.
    • Teva has dorzolamide 2% and timolol 0.5% ophthalmic solution on back order and the company estimates a release date of late-February to early-March 2018.
    • Valeant has dorzolamide 2% and timolol 0.5% ophthalmic solution on back order and the company estimates a release date of mid- to late-February 2018.

Implications for Patient Care

  • Each product contains dorzolamide hydrochloride 22.3 mg/mL (equivalent to dorzolamide 2%) and timolol maleate 6.8 mg/mL (equivalent to timolol 0.5%).

Updated

January 29 and 10, 2018; November 28, October 30, 2017, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide